Mar. 01 2024
Source Page: MHRA grants first approval via the new International Recognition Procedure in 30 daysFound: , is the first product to be authorised by the Medicines and Healthcare products Regulatory Agency (MHRA
Apr. 29 2024
Source Page: Letters and medicine recalls sent to healthcare professionals in March 2024Found: Letters and medicine recalls sent to healthcare professionals in March 2024
Apr. 04 2024
Source Page: Combined antibiotic approved to treat adult patients with severe infections of the urinary tract and hospital-acquired pneumoniaFound: Combined antibiotic approved to treat adult patients with severe infections of the urinary tract and
Mar. 14 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 6 November 2023Found: register of medical practitioners within the United Kingdom) on the prescribing of unlicensed medicines
Mar. 14 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 27 November 2023Found: 2023 to date, specifically mifepristone and misoprostol.
Nov. 21 2023
Source Page: 2019 voluntary scheme for branded medicines pricing and access: heads of agreementFound: 2019 voluntary scheme for branded medicines pricing and access: heads of agreement
May. 03 2024
Source Page: New cabotegravir formulations approved to help prevent HIV-1 infection in adults and adolescentsFound: New cabotegravir formulations approved to help prevent HIV-1 infection in adults and adolescents
Apr. 09 2024
Source Page: Fosdenopterin approved to treat adult patients with molybdenum cofactor deficiency (MoCD) Type AFound: Fosdenopterin approved to treat adult patients with molybdenum cofactor deficiency (MoCD) Type A
Oct. 30 2023
Source Page: MHRA to launch the AI-Airlock, a new regulatory sandbox for AI developersFound: MHRA to launch the AI-Airlock, a new regulatory sandbox for AI developers
Nov. 30 2023
Source Page: Digital mental health technologyFound: Guidance Digital mental health technology A project to enable access to safe and